Jeffrey A. Rona - 26 Feb 2025 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role: CBFO
Signature: /s/ Jason Minio, Attorney-in-Fact
Issuer symbol: OVID
Transactions as of: 26 Feb 2025
Net transactions value: -$2,185
Form type: 4
Filing time: 28 Feb 2025, 16:15:08 UTC
Previous filing: 24 Feb 2025
Next filing: 02 Mar 2026
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OVID	Common Stock	Sale	$2,185	-3,902	-5.4%	$0.5600	67,973	26 Feb 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Content

Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.